# MYCBP2

## Relevance tier by entity

|Entity|Tier|Description                           |
|:------:|:----:|--------------------------------------|
|FL    |2   |relevance in FL not firmly established|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source       |frequency (%)|
|:------:|:-------------:|:-------------:|
|FL    |GAMBL genomes|3            |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |0.120           |1.153           |
|DLBCL |No  |No                   |0.941           |0.000           |
|FL    |No  |No                   |0.850           |7.277           |


> [!NOTE]
> First described in FL in 2021 by [HÃ¼bschmann D](https://pubmed.ncbi.nlm.nih.gov/33953289)


View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/MYCBP2_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/MYCBP2_protein_hg38.html)

![image](images/proteinpaint/MYCBP2_NM_015057.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/MYCBP2.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/MYCBP2_hg38.html)

![image](images/proteinpaint/MYCBP2.svg)
## MYCBP2 Expression
![image](images/gene_expression/MYCBP2_by_pathology.svg)
